StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

Medifast price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Medifast's price to sales ratio was 0.5× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.2× to 1.7×, with a median of 0.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×+0.2
2025Dec 31, 20250.3×−0.0
2024Dec 31, 20240.3×−0.3
2023Dec 29, 20230.6×−0.2
2022Dec 30, 20220.8×−1.0
2021Dec 31, 20211.7×−1.0
2020Dec 31, 20202.7×+0.9
2019Dec 31, 20191.8×−1.6
2018Dec 31, 20183.5×+0.5
2017Dec 29, 20172.9×+1.1
2016Dec 30, 20161.8×+0.5
2015Dec 31, 20151.3×−0.2
2014Dec 31, 20141.5×+0.4
2013Dec 31, 20131.1×−0.1
2012Dec 31, 20121.2×+0.5
2011Dec 30, 20110.7×−1.8
2010Dec 31, 20102.5×–

More Medifast figures

See a number that looks wrong?